Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma

BACKGROUND: In a recently published retrospective case series, Temozolomide was found active as second line approach in advanced ACC patients. The disease control rate obtained, however, was short-lived. We report here an ACC patient with extensive metastatic disease who obtained a remarkable long l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Endocrinol (Lausanne)
Autores principales: Cosentini, Deborah, Turla, Antonella, Carminati, Ornella, Grisanti, Salvatore, Ferrari, Vittorio Domenico, Laganà, Marta, Rosti, Giovanni, Sigala, Sandra, Berruti, Alfredo
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8101262/
https://ncbi.nlm.nih.gov/pubmed/33967965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.674039
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares